Last updated: June 1, 2026
VIBISONE (betamethasone + isoconazole?) Suppliers: Who manufactures and supplies the product and active ingredients?
No complete, citation-backed supplier/marketer/manufacturer dataset can be produced from the information provided.
What companies supply VIBISONE to pharmacies and hospitals?
No VIBISONE-specific supply chain (label holder, marketing authorization holder, primary manufacturer, packer/secondary manufacturer, or wholesale distribution network) can be identified from the prompt.
Which distributor networks handle VIBISONE bulk and finished goods?
No country/market context (e.g., US, EU, UK, India, Middle East, Africa) is provided, so distribution partners and logistics suppliers cannot be mapped.
Which contract manufacturers produce VIBISONE (finished dosage form)?
No formulation/dosage form details (cream/ointment/solution), strength, and market registration details are provided, so manufacturing sites and CMOs cannot be confirmed.
How many manufacturers supply VIBISONE globally?
A global manufacturer count requires: (1) unambiguous product identity (exact active ingredients, strengths, dosage form), (2) the markets where it is marketed, and (3) regulator-linked manufacturing site listings. The prompt contains none of these.
What suppliers provide the active ingredients for VIBISONE?
“VIBISONE” is a brand name used by multiple products in different geographies. Without the exact actives and strengths, sourcing of APIs (contract API manufacturers, royalty-free suppliers, or approved API suppliers) cannot be determined.
Which API manufacturers make the corticosteroid component?
Unresolvable without the exact steroid identity (e.g., betamethasone valerate vs other corticosteroids) and strength.
Which API manufacturers make the antifungal/immunomodulator component?
Unresolvable without the exact co-active identity (e.g., isoconazole vs other antifungals) and strength.
What Orange Book or regulatory listings identify VIBISONE’s suppliers?
Orange Book coverage applies to specific US NDA/ANDA drug products. No US regulatory record can be tied to “VIBISONE” from the prompt alone.
What is the FDA status of VIBISONE and who is the applicant?
Cannot be determined from the input.
What EU national marketing authorizations list the manufacturer and batch-release site?
Cannot be determined without market/country.
Which pharmaceutical contract manufacturers (CMOs) can supply VIBISONE?
A CMO shortlist requires the product’s exact formulation and dossier-linked process/manufacturing details. None are provided.
What sterile vs non-sterile manufacturing lines are used for VIBISONE?
Cannot be determined without dosage form (topical vs oral vs injectable).
When does VIBISONE lose exclusivity and does that change suppliers?
Exclusivity timelines depend on the specific product’s regulatory file, patents, and jurisdiction. No such linkage is possible from the prompt.
What patent estate affects VIBISONE sourcing or generic entry?
Patent analysis requires the underlying active ingredients, jurisdiction, and marketed product identifier. None are provided.
Key Takeaways
- Supplier identification for “VIBISONE” cannot be completed from the provided input.
- Supplier, API source, CMO/manufacturing site, and regulatory listing mapping require an unambiguous product definition (actives, strengths, dosage form, and market).
FAQs
- Is VIBISONE the same product across countries?
- Who is the marketing authorization holder for VIBISONE in the EU?
- Which APIs are used in VIBISONE and who supplies them?
- What contract manufacturers can produce VIBISONE topical formulations?
- Does VIBISONE have an Orange Book or equivalent listing that names suppliers?
References (APA)
-
